EMA Recommends Granting a Marketing Authorisation for Lurbinectedin By Ogkologos - April 30, 2026 39 0 Facebook Twitter Google+ Pinterest WhatsApp It is indicated for the maintenance treatment of adult patients with extensive-stage small cell lung cancer Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Generic Palbociclib Metastasis-Directed Therapy for Oligometastatic Solid Tumours in Histology-Specific Context ctDNA Testing After Neoadjuvant Chemotherapy and Radical Cystectomy Predicts Recurrence Risk in Patients with MIBC MOST POPULAR Virtual Mind–Body Fitness Classes Show Unexpected Benefit in People with Cancer December 15, 2023 How to Strengthen Your Immune System: Part 2 September 18, 2020 MGUS to Myeloma: Study Suggests Risk of Progression Can Change August 13, 2019 Our COVID-19 Response: How We’re Supporting Frontline Workers At Revolution Foods April 27, 2020 Load more HOT NEWS How My Navy Career Helped Shape My Positive Attitude During My... When Breast Cancer Patient Comes Into His Shop, Barber Shaves His... Washington Farmers Harvest Crops For Neighbor With Stage Four Cancer Longitudinal Molecular Profiling of CTCs Captures New Insights in mRCC
